Emerging in the field of weight management management, retatrutide presents a distinct method. Unlike many available medications, retatrutide operates as a twin agonist, at once targeting both GLP peptide-1 (GLP-1) and glucose-sensitive insulinotropic polypeptide (GIP) receptors. The dual stimulation promotes various advantageous effects, such as i